Back

BRM preserves sinusoidal niche integrity to prevent microenvironmental senescence and sustain hematopoietic stem cells

Suzuki, H.; Miyachi, H.; Yamada, N.; Kuno, S.; Nishikawa, H.; Shiina, T.; Endoh, H.; Uemura, S.; Suda, T.; Iwama, A.; Nitta, R.; Nitta, E.

2026-07-08 immunology
10.64898/2026.07.03.736310 bioRxiv
Show abstract

compromises hematopoietic stem cell (HSC) maintenance, contributing to an extrinsic HSC aging phenotype. Although niche-derived Notch signaling is essential for hematopoietic regeneration following myelosuppressive injury, the upstream epigenetic mechanisms that regulate this stress-responsive signaling remain poorly understood. Here, we identify the chromatin remodeler BRM (SMARCA2) as a critical regulator of the BM sinusoidal niche that preserves vascular integrity and hematopoietic regeneration. Using reciprocal BM transplantation, we demonstrate that a Brm-deficient microenvironment impairs HSC repopulating capacity and imposes an aging-like myeloid bias characterized by expansion of granulocyte-monocyte progenitors. Following 5-fluorouracil (5-FU)-induced myelosuppression, BrmKO mice exhibit defective sinusoidal regeneration accompanied by endothelial degeneration. Mechanistically, BRM deficiency attenuates endothelial Notch signaling by impairing stress-induced Notch2 expression in sinusoidal endothelial cells (SECs), while simultaneously reducing Jag2 ligand pool through persistent depletion of SECs and impaired stress-induced expansion of Jag2-producing LepR-positive stromal cells. These alterations attenuate endothelial Notch signaling, resulting in defective sinusoidal regeneration, loss of mesenchymal niche support, and progressive displacement of HSCs from the sinusoidal vasculature. Notably, Brm expression is physiologically reduced in aged wild-type SECs and LepR-positive stromal cells. Collectively, our findings identify BRM as a key epigenetic regulator of bone marrow niche integrity and suggest that age-associated BRM decline contributes to niche dysfunction and hematopoietic aging.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
Cell Reports
1498 papers in training set
Top 0.5%
15.3%
2
Journal of Experimental Medicine
119 papers in training set
Top 0.1%
12.1%
3
eLife
5828 papers in training set
Top 12%
8.0%
4
Nature Communications
5641 papers in training set
Top 23%
6.8%
5
Immunity
67 papers in training set
Top 0.2%
6.3%
6
EMBO Reports
263 papers in training set
Top 0.8%
4.9%
50% of probability mass above
7
Journal of Clinical Investigation
179 papers in training set
Top 1%
4.1%
8
JCI Insight
277 papers in training set
Top 3%
2.8%
9
The Journal of Immunology
166 papers in training set
Top 1%
2.7%
10
Aging Cell
165 papers in training set
Top 1%
2.1%
11
Stem Cell Reports
130 papers in training set
Top 0.9%
2.1%
12
Proceedings of the National Academy of Sciences
2444 papers in training set
Top 23%
2.1%
13
Blood
74 papers in training set
Top 0.7%
2.1%
14
Science Advances
1243 papers in training set
Top 20%
1.7%
15
The EMBO Journal
309 papers in training set
Top 3%
1.7%
16
Cell Death & Disease
21 papers in training set
Top 0.3%
1.1%
17
Frontiers in Immunology
638 papers in training set
Top 7%
1.1%
18
Cell Stem Cell
62 papers in training set
Top 1%
1.1%
19
Nature Immunology
79 papers in training set
Top 2%
1.1%
20
Science Translational Medicine
127 papers in training set
Top 3%
1.0%
21
Advanced Science
286 papers in training set
Top 8%
1.0%
22
EMBO Molecular Medicine
95 papers in training set
Top 2%
0.9%
23
Cell Metabolism
57 papers in training set
Top 1%
0.9%
24
Development
497 papers in training set
Top 5%
0.6%
25
Cancer Discovery
66 papers in training set
Top 2%
0.6%
26
Nature Aging
60 papers in training set
Top 2%
0.6%